Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naïve Adults With HIV-1
• Committee for Medicinal Products for Human Use (CHMP) Recommends Granting Marketing Authorisation for FIRMAGON(R) (degarelix) for Treatment of Prostate Cancer
• CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
• Studies Assessed by European Health Authority Conclude That Impurity in Roche's Viracept(R) (nelfinavir mesylate) Did Not Increase Patient's Risk of Cancer
• INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
• Valdoxan(R), das erste melatonerge Antidepressivum, erhält eine positive Empfehlung des EU-Ausschusses für Humanarzneimittel CHMP für die Behandlung von Depressionen im klinischen Sinn (MDD)
• IDM Pharma erhält Empfehlung des Ausschusses für Humanarzneimittel (CHMP) für die Zulassung von Mifamurtid ((MEPACT(R), L-MTP-PE) zur Behandlung von Patienten mit nicht metastasierendem resezierbarem Osteosarkom in Europa
• New Biologic Ustekinumab Receives Positive Opinion From European Regulatory Authority for the Treatment of Moderate to Severe Plaque Psoriasis
• New Antibiotic Against Serious Infections
• Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union

Presseportal: Tibotec Pharmaceuticals Ltd. - Tibotec gibt Beginn der ...

European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in

ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

INTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal.Products (CHMP) for Treatment of HIV = 27.06.2008 / 08:07

European Committee for Human Medicinal Products (CHMP) Issues Positive ...

INTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal Products (CHMP) for Treatment of HIV

Presseportal: Tibotec Pharmaceuticals Ltd. - HIV/AIDS-Patienten ...

INTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal Products (CHMP) for Treatment of HIV

Presseportal.de - Tibotec Pharmaceuticals Ltd.

INTELENCE(TM) (etravirine) Receives Positive Opinion From European Committee for Human Medicinal Products (CHMP) for Treatment of HIV